Mechanistic contributions of FBXO7 to Parkinson disease

Publisher： John Wiley & Sons Inc

E-ISSN： 1471-4159|144|2|118-127

ISSN： 0022-3042

Source： JOURNAL OF NEUROCHEMISTRY (ELECTRONIC), Vol.144, Iss.2, 2018-01, pp. : 118-127

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Oxidative Neurodegeneration Is Prevented by UCP0045037, an Allosteric Modulator for the Reduced Form of DJ-1, a Wild-Type of Familial Parkinson’s Disease-Linked PARK7

By Yamane Koichiro   Kitamura Yoshihisa   Yanagida Takashi   Takata Kazuyuki   Yanagisawa Daijiro   Taniguchi Takashi   Taira Takahiro   Ariga Hiroyoshi  

International Journal of Molecular Sciences, Vol. 10, Iss. 11, 2009-11 ,pp. : 4789-4804

MDPI

Access to resources Recommend Favorite

Protein Kinases and Parkinson’s Disease

By Mehdi Syed Jafar   Rosas-Hernandez Hector   Cuevas Elvis   Lantz Susan M.   Barger Steven W.   Sarkar Sumit   Paule Merle G.   Ali Syed F.   Imam Syed Z.  

International Journal of Molecular Sciences, Vol. 17, Iss. 9, 2016-09 ,pp. : 1585-1585

MDPI

Access to resources Recommend Favorite

Olfactory Dysfunction in Parkinson’s Disease

By  

Neurosignals, Vol. 16, Iss. 1, 2007-12 ,pp. : 35-40

Karger

Access to resources Recommend Favorite

Resting‐State Functional Brain Networks in Parkinson's Disease

By  

CNS: NEUROSCIENCE AND THERAPEUTICS, Vol. 1755-5930, Iss. 10, 2015-10 ,pp. : 793-801

John Wiley & Sons Inc

Access to resources Recommend Favorite

Metaanalyses of seven GIGYF2 polymorphisms with Parkinson's disease

By                              

Biomedical Reports, Vol. 2, Iss. 6, 2014-01 ,pp. : 886-892

Spandidos Publications

Access to resources Recommend Favorite